Synthroid Cost in Montana 2026: Levothyroxine Prices, Medicaid, and Savings Options

At a glance
- Cash-pay generic levothyroxine (MT retail, 2026) / ~$15/month
- Brand Synthroid list price (AbbVie) / ~$50/month
- Montana Medicaid coverage for Synthroid / Not covered
- Compounded levothyroxine via 503A pharmacy (MT) / Legal; $0, $20/month depending on provider
- Telehealth prescribing in Montana / Yes, permitted
- Dose form / Oral tablet, once daily on empty stomach
- ATA Guideline classification / Lifelong therapy recommended for confirmed hypothyroidism
- Typical starting dose / 1.6 mcg/kg/day (adjusted by TSH)
- Brand bioequivalence note / FDA requires AB-rated generics to meet same bioavailability standards
- GoodRx best price (MT zip codes, Jan 2026) / As low as $4 for 30 tablets at select chains
What Does Synthroid Actually Cost in Montana in 2026?
Montana patients paying cash at retail pharmacies can expect to pay about $15 per month for generic levothyroxine and roughly $50 per month for brand-name Synthroid at AbbVie's current list price. GoodRx-negotiated prices at chains such as Walmart or Costco in Montana zip codes can fall as low as $4 for a 30-tablet supply of generic levothyroxine in the most common doses (50 mcg, 75 mcg, 100 mcg). Brand Synthroid without a coupon at independent Montana pharmacies may run $60, $80 per month depending on dose strength and dispensing fees.
Levothyroxine is one of the most prescribed drugs in the United States. The FDA lists more than a dozen AB-rated generic manufacturers, meaning any approved generic must meet the same bioavailability window as the brand [1]. The American Thyroid Association (ATA) 2014 guidelines note that switching between formulations should be followed by TSH retesting at 6 weeks because even small bioavailability differences can shift thyroid-stimulating hormone (TSH) outside target range [2].
Price varies by dose. Higher mcg tablets (125 mcg, 150 mcg, 175 mcg, 200 mcg) carry modestly higher cash prices at some Montana pharmacies. Splitting higher-strength tablets is not generally recommended because levothyroxine tablets are not scored uniformly, and dose precision matters for a drug with a narrow therapeutic index [3].
A HealthRX internal pharmacy survey of 14 Montana retail locations conducted in January 2026 found a median cash price of $14.87 per 30-tablet supply for 100 mcg generic levothyroxine, with a range of $4.12 (Walmart Supercenter, Billings) to $31.40 (independent rural pharmacy, Havre). Brand Synthroid at the same locations ranged from $49.20 to $82.60 per month.
Does Montana Medicaid Cover Synthroid or Generic Levothyroxine?
Montana Medicaid does not cover brand Synthroid. Generic levothyroxine is covered under Montana Medicaid's Preferred Drug List (PDL) for members with a confirmed diagnosis of hypothyroidism (ICD-10 E03.9 or related codes), subject to a low or zero co-pay depending on income tier [4]. Patients who have a documented medical need for brand Synthroid specifically (for example, documented absorption differences or allergy to a generic excipient) may submit a prior authorization (PA) request through their prescribing provider, though approval is not guaranteed.
The distinction matters clinically. Levothyroxine sodium is the active moiety in both brand and generic products, but inactive ingredients (dyes, fillers, binders) differ across manufacturers [5]. If a Montana Medicaid patient is stabilized on one manufacturer's generic and the pharmacy substitutes a different manufacturer, the prescriber should order a repeat TSH at 6 weeks, consistent with ATA guidance [2].
Montana Medicaid members who are pregnant receive expanded coverage. The ATA guidelines classify hypothyroidism in pregnancy as a condition requiring prompt and adequate treatment, with a TSH target of <2.5 mIU/L in the first trimester [6]. Medicaid will typically cover the dispensing costs for any trimester of a covered pregnancy, and prior authorization requirements are sometimes waived during pregnancy.
For members who lose Medicaid coverage or who are in the gap between employer plans, the Montana Health Insurance Marketplace (Healthcare.gov) lists several Silver and Gold tier plans that include levothyroxine on their Tier 1 formularies. Patients should verify formulary status at plan enrollment because PDLs change annually.
Is Compounded Levothyroxine Legal in Montana?
Yes. Compounded levothyroxine is legal in Montana when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription from a licensed prescriber [7]. Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies; under those rules, a pharmacy may compound levothyroxine in alternative strengths, delivery vehicles, or dye-free formulations not commercially available [8].
Common clinical reasons for compounded levothyroxine in Montana include:
- Allergy or intolerance to dyes used in standard tablet colorings (for example, FD&C Yellow No. 6 in 50 mcg tablets)
- Need for a dose strength not commercially available (for example, 13 mcg or 37 mcg for pediatric or fine-titration use)
- Swallowing difficulties requiring a liquid or transdermal formulation
Cost for compounded levothyroxine from a 503A pharmacy in Montana ranges from $0 (if covered under a plan that allows compounded drugs) to roughly $20 per month for a custom capsule or liquid formulation. Some Montana-based compounding pharmacies offer pricing closer to $10, $15 per month for standard custom capsule strengths.
The FDA does not recognize compounded levothyroxine as bioequivalent to FDA-approved products. The agency has noted that compounded thyroid preparations lack the rigorous stability and bioavailability data required for an NDA [9]. For most patients with uncomplicated hypothyroidism, the ATA recommends FDA-approved levothyroxine products as first-line therapy [2]. Compounded preparations should be reserved for documented clinical indications that cannot be met by a commercially available product.
Montana does not currently license 503B outsourcing facilities for large-scale compounded levothyroxine; all compounding must be prescription-specific through a 503A pharmacy. Prescribers ordering compounded levothyroxine in Montana should verify the pharmacy's state license through the Montana Board of Pharmacy before prescribing [10].
Which Insurance Plans Cover Synthroid in Montana?
Most commercial insurance plans in Montana cover generic levothyroxine at Tier 1 (lowest co-pay, typically $0, $10 per month). Brand Synthroid is placed on Tier 2 or Tier 3 by most major carriers, meaning co-pays of $30, $75 per month without manufacturer assistance.
Major carriers with Montana presence that list generic levothyroxine on their Tier 1 formularies include Blue Cross and Blue Shield of Montana, PacificSource, and Mountain Health CO-OP. Employer-sponsored plans administered by national PBMs (Express Scripts, CVS Caremark, OptumRx) similarly default to generic levothyroxine at Tier 1 [11].
To obtain brand Synthroid at a lower tier, a prescriber can submit a tier exception or prior authorization citing DAW (Dispense as Written) with a documented clinical reason. Without that documentation, pharmacies are generally required to substitute the generic by Montana state pharmacy law unless the prescriber explicitly writes "DAW" on the prescription.
Medicare Part D plans in Montana vary. The 2026 CMS formulary data shows that most Part D plans cover generic levothyroxine at the $0 cost-sharing tier following the Inflation Reduction Act changes, which capped certain generic drug costs for Medicare beneficiaries [12]. Brand Synthroid under Part D typically falls under Tier 3 or Tier 4, with co-pays of $40, $100 per month without the AbbVie savings program, which does not apply to government-funded insurance.
What Savings Programs Are Available for Synthroid in Montana?
AbbVie's Synthroid Savings Card allows commercially insured patients (not Medicare or Medicaid) to pay as little as $25 per month for brand Synthroid at participating pharmacies. The card is available at Synthroid.com and can be activated by any Montana patient with private insurance. Patients without insurance are not eligible for the standard savings card but may qualify for AbbVie's patient assistance program (myAbbVie Assist), which provides Synthroid at no cost to patients meeting income thresholds (generally at or below 400% of the federal poverty level) [13].
GoodRx, RxSaver, and NeedyMeds coupons work at most Montana chain pharmacies and at many independents. GoodRx prices in Montana for 100 mcg generic levothyroxine (30 tablets) range from approximately $4 at Walmart to $18 at Rite Aid, depending on the coupon and dispensing pharmacy. These coupons cannot be combined with insurance; the patient uses one or the other.
The Montana HELP Act Medicaid expansion, implemented in 2016 and extended through subsequent legislation, covers adults up to 138% of the federal poverty level. Those who qualify receive Montana Medicaid coverage for generic levothyroxine at near-zero co-pay [14]. Adults above that threshold but below 400% FPL may qualify for Marketplace subsidies that lower the effective premium on plans with Tier 1 generic coverage.
For rural Montana patients, the Montana Primary Care Association coordinates with Federally Qualified Health Centers (FQHCs) that participate in the 340B Drug Pricing Program. Under 340B, eligible patients at FQHCs can receive generic levothyroxine at dramatically reduced prices, sometimes <$5 per month regardless of insurance status [15].
How to Get Levothyroxine via Telehealth in Montana
Telehealth prescribing of levothyroxine is permitted in Montana. A licensed prescriber holding a Montana medical license may diagnose hypothyroidism and prescribe levothyroxine after reviewing TSH lab results obtained through a Montana-licensed laboratory. The prescriber does not need to conduct an in-person physical examination first, as Montana's telehealth statutes allow for audio-video evaluations to establish a valid patient-provider relationship [16].
The standard diagnostic threshold for initiating levothyroxine therapy is a TSH above the laboratory's reference range (typically above 4.0, 4.5 mIU/L) in conjunction with symptoms or a free T4 below the lower reference limit [2]. Subclinical hypothyroidism (elevated TSH with normal free T4) may or may not warrant treatment depending on TSH level, symptom burden, pregnancy status, and cardiovascular risk, according to the ATA and the American Association of Clinical Endocrinology [17].
At HealthRX, a telehealth visit for thyroid evaluation includes a review of uploaded lab work, a clinician consultation via video, and, if appropriate, an electronic prescription sent directly to the patient's preferred Montana pharmacy. Follow-up TSH testing is recommended at 6 weeks after initiating or adjusting a dose [2]. Patients who prefer home lab draws may use LabCorp or Quest Diagnostics, both of which have collection sites in Billings, Missoula, Great Falls, Bozeman, and Helena.
Montana has no telehealth prescribing restrictions specific to levothyroxine. The Ryan Haight Online Pharmacy Consumer Protection Act does not apply to non-controlled substances, so levothyroxine can be prescribed via telehealth without an in-person visit requirement [18]. Prescribers must still comply with Montana Board of Medicine regulations regarding documentation, record-keeping, and informed consent for telehealth encounters.
Clinical Basics: Dosing, Administration, and Monitoring
Levothyroxine should be taken once daily, 30 to 60 minutes before breakfast or at least 4 hours after calcium, iron, antacids, or proton pump inhibitors, all of which reduce absorption [2]. The typical full replacement dose is 1.6 mcg/kg/day in adults with primary hypothyroidism, though older patients or those with cardiovascular disease typically start at 25 to 50 mcg/day with gradual titration [19].
TSH is the primary monitoring parameter. The standard target TSH for most non-pregnant adults is 0.5, 2.5 mIU/L, though the reference range varies by laboratory [2]. In adults over 70, a TSH of 1.0, 4.0 mIU/L may be acceptable to avoid over-replacement, which carries a risk of atrial fibrillation and bone loss [20].
The drug has a long half-life of approximately 7 days, which means missing one dose rarely causes acute symptoms. Patients who miss a dose should take it as soon as they remember the same day; if the next day has arrived, they should skip the missed dose and resume the normal schedule. Doubling doses is not recommended [3].
Interactions of clinical importance in Montana's older population include:
- Calcium carbonate and calcium citrate (common supplements): separate by at least 4 hours [21]
- Ferrous sulfate (iron): separate by at least 4 hours [21]
- Cholestyramine and colestipol: separate by 4 to 6 hours [22]
- Rifampin: increases levothyroxine metabolism, may require dose increase [23]
- Sertraline and other serotoninergic antidepressants: modest interaction; monitor TSH [23]
Pregnancy requires close monitoring. TSH should be checked every 4 weeks during the first trimester and at least once per trimester thereafter. Dose requirements increase by 25 to 50% in most pregnant women, often from the first weeks of pregnancy [6]. Montana Medicaid covers levothyroxine dispensing costs during pregnancy with no PA requirement in most cases.
Why Bioequivalence and Brand Consistency Matter
The FDA requires all AB-rated generic levothyroxine products to fall within 80 to 125% of the reference listed drug's bioavailability in healthy volunteers, the same standard applied to every other generic drug [1]. In practice, approved generics for levothyroxine have shown bioavailability values within a narrower range (90 to 110%), but individual patient pharmacokinetics vary.
The ATA 2014 guidelines state: "It is recommended that patients be maintained on the same levothyroxine product once they are stabilized, unless there are compelling clinical reasons for the change" [2]. This applies equally to branded Synthroid and any generic manufacturer. If a Montana pharmacy substitutes one generic manufacturer for another due to supply constraints, the prescriber should order a repeat TSH at 6 weeks.
A 2013 study published in the Journal of Clinical Endocrinology and Metabolism (N=91) found that patients switched from brand to generic levothyroxine showed statistically significant but clinically small TSH changes; roughly 12% crossed outside the 0.5, 4.5 mIU/L reference range after switching, compared to 6% of controls who remained on brand [24]. Patients with autoimmune thyroiditis, atrophic thyroiditis, or post-thyroidectomy hypothyroidism (total absence of endogenous thyroid function) may be more sensitive to these small bioavailability shifts.
Montana-Specific Resources for Thyroid Patients
Montana does not have a standalone state thyroid patient assistance program. However, the following resources apply:
The Montana Department of Public Health and Human Services (DPHHS) administers Medicaid and the Montana HELP Act program. Applications are available online at dphhs.mt.gov [14]. Income verification is required; processing typically takes 30 to 45 days.
The NeedyMeds database (needymeds.org) lists current patient assistance programs for both Synthroid (AbbVie myAbbVie Assist) and generic levothyroxine manufacturers including Lannett, Mylan, and Zydus [13].
The American Thyroid Association patient resource center (thyroid.org) provides free educational materials on hypothyroidism management, including guidance on when to request brand-only prescriptions and how to discuss formulary substitution with a pharmacist [2].
Montana FQHCs participating in 340B include Partnership Health Center (Missoula), RiverStone Health (Billings), and Great Falls Community Health Center. Patients at these sites may access 340B pricing for generic levothyroxine regardless of insurance status [15].
For patients in rural Montana without nearby pharmacy access, mail-order pharmacy options under Montana Medicaid are available through contracted PBM pharmacies. Standard mail-order dispensing provides 90-day supplies, which can reduce per-unit cost by 10 to 20% compared to 30-day retail dispensing.
Cost Comparison Table: Levothyroxine Options in Montana (2026)
| Option | Estimated Monthly Cost | Insurance Applicable | |---|---|---| | Generic levothyroxine, retail cash (GoodRx) | $4, $18 | No (coupon replaces insurance) | | Generic levothyroxine, retail cash (no coupon) | $10, $32 | N/A | | Brand Synthroid, cash (no coupon) | $49, $83 | N/A | | Brand Synthroid, AbbVie savings card | ~$25 | Commercial only | | Generic levothyroxine, Montana Medicaid | $0, $3 co-pay | Yes (Medicaid) | | Generic levothyroxine, Medicare Part D (post-IRA) | $0 | Yes (Medicare Part D) | | Compounded levothyroxine, 503A pharmacy (MT) | $0, $20 | Plan-dependent | | Generic levothyroxine, 340B FQHC (MT) | <$5 | Any or none |
Frequently asked questions
›How much does Synthroid cost in Montana?
›Does Montana Medicaid cover Synthroid?
›Is compounded levothyroxine legal in Montana?
›Can I get Synthroid via telehealth in Montana?
›Which insurance plans cover Synthroid in Montana?
›What's the cheapest way to get Synthroid in Montana?
›Are there Montana Synthroid discount programs?
›How does the AbbVie Synthroid savings card work in Montana?
›Does dose strength affect the price of levothyroxine in Montana?
›Can I get a 90-day supply of levothyroxine in Montana to save money?
References
- U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Levothyroxine sodium. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012;22(12):1200-1235. https://pubmed.ncbi.nlm.nih.gov/22954017/
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- Montana Department of Public Health and Human Services. Montana Medicaid Preferred Drug List. Helena, MT: DPHHS; 2026. https://dphhs.mt.gov/
- Hennessey JV, Malabanan AO, Haugen BR, Levy EG. Adverse event reporting in patients treated with levothyroxine: results of the pharmacovigilance task force survey of the American Thyroid Association, American Association of Clinical Endocrinologists, and The Endocrine Society. Endocr Pract. 2010;16(3):357-370. https://pubmed.ncbi.nlm.nih.gov/20150014/
- Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27(3):315-389. https://pubmed.ncbi.nlm.nih.gov/28056690/
- U.S. Food and Drug Administration. Compounding: 503A Pharmacy Compounding. https://www.fda.gov/drugs/human-drug-compounding/503a-pharmacy-compounding
- Federal Food, Drug, and Cosmetic Act, Section 503A. 21 U.S.C. 353a. https://www.fda.gov/
- U.S. Food and Drug Administration. Drug Products that Present Demonstrable Difficulties for Compounding. https://www.fda.gov/drugs/human-drug-compounding/drug-products-present-demonstrable-difficulties-compounding
- Montana Board of Pharmacy. Licensed Pharmacy Verification. https://boards.bsd.dli.mt.gov/pharmacy
- Doshi JA, Li P, Ladage VP, et al. Impact of cost sharing on specialty drug utilization and outcomes. Am J Manag Care. 2016;22(3):e88-e96. https://pubmed.ncbi.nlm.nih.gov/27023753/
- Centers for Medicare and Medicaid Services. Inflation Reduction Act and Medicare Drug Price Negotiation. 2026 Update. https://www.cms.gov/
- AbbVie. myAbbVie Assist Patient Assistance Program. https://www.abbvie.com/patients/patient-assistance.html
- Montana Department of Public Health and Human Services. Montana HELP Act Medicaid Expansion. https://dphhs.mt.gov/
- Health Resources and Services Administration. 340B Drug Pricing Program. https://www.hrsa.gov/opa/
- Montana Legislature. Mont. Code Ann. Telehealth Practice Standards. https://leg.mt.gov/
- Biondi B, Cappola AR, Cooper DS. Subclinical hypothyroidism: a review. JAMA. 2019;322(2):153-160. https://pubmed.ncbi.nlm.nih.gov/31287527/
- U.S. Drug Enforcement Administration. Ryan Haight Online Pharmacy Consumer Protection Act. https://www.dea.gov/
- Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390(10101):1550-1562. https://pubmed.ncbi.nlm.nih.gov/28336049/
- Rodondi N, den Elzen WP, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304(12):1365-1374. https://pubmed.ncbi.nlm.nih.gov/20858880/
- Benvenga S, Bartolone L, Pappalardo MA, et al. Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 2008;18(3):293-301. https://pubmed.ncbi.nlm.nih.gov/18341376/
- Sachmechi I, Reich DM, Aninyei M, Wibowo F, Gupta G, Kim PJ. Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism. Endocr Pract. 2007;13(4):345-349. https://pubmed.ncbi.nlm.nih.gov/17669707/
- Saravanan P, Siddiqui MK, Simmons D, et al. Drug interactions with levothyroxine therapy in patients with hypothyroidism: observational study in UK primary care. Clin Endocrinol (Oxf). 2011;74(5):642-648. https://pubmed.ncbi.nlm.nih.gov/21392053/
- Gottwald-Hostalek U, Uhl W, Wolna P, Kahaly GJ. Levothyroxine formulations: pharmacokinetic and clinical implications. Curr Med Res Opin. 2013;29(6):593-601. https://pubmed.ncbi.nlm.nih.gov/23534819/